Jibe Therapeutics, which is developing a next-gen cancer treatment that helps the immune system better recognize and attack tumors, won the “golden ticket” in a pitch competition. The victory comes with one year of fully paid bench space and membership at Biolabs in Pegasus Park. Jibe also gets a $25,000 cash prize. Jibe Co-Founder and CEO Austin Boesch is based in Somerville, Massachusetts, but the company is relocating research operations to Pegasus Park.